Age Management Medicine
Learn more with our

FREE E-BOOK and our
FREE E-NEWSLETTERS CLICK HERE

Make an Appointment Marc Darrow, M.D.,J.D. Joint Rehabilitation Services
11645 Wilshire Blvd., Suite 120 Los Angeles, CA 90025 (310) 231-7000

Watch
Videos

Testosterone-insulin sensitivity and men with heart failure
Researchers writing in the European Journal of Heart Failure say "Testosterone improves fasting insulin sensitivity in men with chronic heart failure and may also increase lean body mass, these data suggest a favourable effect of testosterone on an important metabolic component of chronic heart failure"

Malkin CJ, Jones TH, Channer KS. The effect of testosterone on insulin sensitivity in men with heart failure.European Journal of Heart Failure 2007 Jan;9(1):44-50.


Resistance to insulin occurs in chronic heart failure (CHF) and is related to prognosis.

Studies of testosterone in non-(CHF) males suggest that physiological testosterone therapy improves insulin sensitivity.

This was a single-blind placebo controlled crossover trial to determine the effect of testosterone replacement on insulin sensitivity in 13 men with moderate to severe CHF (ejection fraction 30.5+/-1.3). The primary outcome was the homeostatic model index (HOMA-IR) of fasting insulin sensitivity and secondary outcomes were body composition as measured by bioelectrical impedance and glucose tolerance to a standard 75 g oral glucose load. Analysis was performed on the delta values with the treatment effect of placebo compared with that of testosterone. At baseline HOMA-IR correlated with measures of body fat [% fat mass (rP=0.84, p=0.0001) and body mass index (rP=0.79, p=0.01)] but not with CHF severity.

Testosterone reduced HOMA-IR (-1.9+/-0.8, p=0.03) indicating improved fasting insulin sensitivity. Testosterone also increased total mass (+1.5+/-0.5 kg, p=0.008) and decreased body fat (-0.8+/-0.3%, p=0.02).

Testosterone improves fasting insulin sensitivity in men with CHF and may also increase lean body mass, these data suggest a favourable effect of testosterone on an important metabolic component of CHF.

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=16828341
 

Ageless
Suzanne Somers

"As my personal sports doctor, (Dr. Darrow) has never given me a drug for any of my injuries. He is of the thinking that unless a drug is necessary, it is better to allow inflammation to do nature's work." (page 130).

Patient Information
Joint Rehabilitation and Prolotherapy Information
Marc Darrow, M.D.,J.D.,Q.M.E.

Marc Darrow, M.D., J.D.,
is an Assistant Clinical Professor at UCLA School of Medicine. He is a world recognized specialist in many chronic disorders. He has been featured in national publications, and television and radio shows, for his innovative approach to medicine. As the medical director of Joint Rehab Center, Inc. in West Los Angeles, Dr. Darrow has helped create an age management program for those individuals interested in maintaining a youthful, healthy vigor for adults through “middle age” and well into the senior years.


Why am I so driven to work in the age management field? Basically it was for my own personal, mental, and spiritual well being.
Read what Dr. Darrow has to say about how he got interested in age management!

DISCLAIMER:
Neither Dr. Darrow, nor any associate of JOINT REHAB AND SPORTS MEDICAL CENTER, INC offer medical advice from this website. This information is offered for educational purposes only. Do not act or rely upon our information without seeking independent professional medical advice. The information on this website does not create a physician-patient relationship between you and Dr. Darrow or any associate of JOINT REHAB AND SPORTS MEDICAL CENTER, INC. Neither Dr. Darrow, nor any associate of JOINT REHAB AND SPORTS MEDICAL CENTER, INC guarantees the accuracy, completeness, usefulness, or adequacy of any resources, information, apparatus, product, or process available at or from this website. MEDICAL MODALITIES MENTIONED ARE MEDICAL TECHNIQUES THAT MAY NOT BE CONSIDERED MAINSTREAM. AS WITH ANY MEDICAL PROCEDURE, RESULTS WILL VARY AMONG INDIVIDUALS, AND THERE COULD BE SUBSTANTIAL RISKS INVOLVED. THESE CONCERNS SHOULD BE DISCUSSED WITH YOUR HEALTH CARE PROVIDER PRIOR TO ANY TREATMENT SO THAT YOU HAVE PROPER INFORMED CONSENT AND UNDERSTAND THAT THERE ARE NO GUARANTEES TO HEALING.

Certain studies including the Woman's Health Initiative suggest that hormone supplementation may increase the risk of certain cancers, heart disease, stroke and other ailments. These risks should be discussed with your health care professional while deciding on, implementing, or continuing Hormone Replacement Therapy (HRT)

The option to use Human Identical Hormones or Bio-identical hormones should also be discussed with your medical care provider as there is not sufficient medical evidence at this time to suggest that they are safer than synthetic hormones and may pose equal risk.

If you have or suspect that you have a medical problem, condition or issue, promptly contact your health care provider. The statements on this website have not been evaluated by the Food and Drug Administration. The photos in this Web site feature models for illustrative purposes.